Novel microdialysis method to assess neuropeptides and large molecules in free-moving mouse

Neuroscience

Volumn 186, Issue , 2011, Pages 110-119

  Takeda, S ^a   Sato, N ^a   Ikimura, K ^b   Nishino, H ^b   Rakugi, H ^a   Morishita, R ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Research and Development   (Japan)

Author keywords

Beta amyloid; In vivo sampling; Inflammatory cytokine; Large molecule; Microdialysis

Indexed keywords

AMYLOID BETA PROTEIN; CYTOKINE; INTERLEUKIN 6; NEUROPEPTIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; IN VIVO STUDY; INTERSTITIUM; MICRODIALYSIS; MONITORING; MOUSE; NONHUMAN; PRIORITY JOURNAL; SAMPLING; WAKEFULNESS;

ANIMALS; BRAIN CHEMISTRY; CYTOKINES; EXTRACELLULAR FLUID; FEMALE; HUMANS; MICE; MICE, TRANSGENIC; MICRODIALYSIS; MOLECULAR DYNAMICS SIMULATION; NEUROPEPTIDES;

EID: 79957973834     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.04.035     Document Type: Article

References (23)

1. Amor S., Puentes F., Baker D., van der Valk P. Inflammation in neurodegenerative diseases. Immunology 2010, 129:154-169.
2. Ao X., Stenken J.A. Microdialysis sampling of cytokines. Methods 2006, 38:331-341.
3. Asai S., Kohno T., Ishii Y., Ishikawa K. A newly developed procedure for monitoring of extracellular proteins using a push-pull microdialysis. Anal Biochem 1996, 237:182-187.
4. Cao C., Cirrito J.R., Lin X., Wang L., Verges D.K., Dickson A., Mamcarz M., Zhang C., Mori T., Arendash G.W., Holtzman D.M., Potter H. Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice. J Alzheimers Dis 2009, 17:681-697.
5. Chaurasia C.S. In vivo microdialysis sampling: theory and applications. Biomed Chromatogr 1999, 13:317-332.
6. Cirrito J.R., May P.C., O'Dell M.A., Taylor J.W., Parsadanian M., Cramer J.W., Audia J.E., Nissen J.S., Bales K.R., Paul S.M., DeMattos R.B., Holtzman D.M. In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life. J Neurosci 2003, 23:8844-8853.
7. Clough G.F. Microdialysis of large molecules. AAPS J 2005, 7:E686-E692.
8. Cremers T.I., de Vries M.G., Huinink K.D., van Loon J.P., v d Hart M., Ebert B., Westerink B.H., De Lange E.C. Quantitative microdialysis using modified ultraslow microdialysis: direct rapid and reliable determination of free brain concentrations with the MetaQuant technique. J Neurosci Methods 2009, 178:249-254.
9. Elmquist W.F., Sawchuk R.J. Application of microdialysis in pharmacokinetic studies. Pharmacol Res 1997, 14:267-288.
10. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
11. Humpel C., Ebendal T., Olson L. Microdialysis: a way to study in vivo release of neurotrophic bioactivity: a critical summary. J Mol Med 1996, 74:523-526.
12. Jensen S.M., Hansen H.S., Johansen T., Malmlof K. In vivo and in vitro microdialysis sampling of free fatty acids. J Pharm Biomed Anal 2007, 43:1751-1756.
13. Kendrick K.M. Microdialysis measurement of in vivo neuropeptide release. J Neurosci Methods 1990, 34:35-46.
14. Lada M.W., Kennedy R.T. Quantitative in vivo monitoring of primary amines in rat caudate nucleus using microdialysis coupled by a flow-gated interface to capillary electrophoresis with laser-induced fluorescence detection. Anal Chem 1996, 68:2790-2797.
15. Maurer M.H. Proteomics of brain extracellular fluid (ECF) and cerebrospinal fluid (CSF). Mass Spectrom Rev 2010, 29:17-28.
16. Mellergard P., Aneman O., Sjogren F., Pettersson P., Hillman J. Changes in extracellular concentrations of some cytokines, chemokines, and neurotrophic factors after insertion of intracerebral microdialysis catheters in neurosurgical patients. Neurosurgery 2008, 62:151-157. discussion:157-158.
17. Riese J., Boecker S., Hohenberger W., Klein P., Haupt W. Microdialysis: a new technique to monitor perioperative human peritoneal mediator production. Surg Infect (Larchmt) 2003, 4:11-15.
18. Sjogren F., Svensson C., Anderson C. Technical prerequisites for in vivo microdialysis determination of interleukin-6 in human dermis. Br J Dermatol 2002, 146:375-382.
19. Sopasakis V.R., Sandqvist M., Gustafson B., Hammarstedt A., Schmelz M., Yang X., Jansson P.A., Smith U. High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator. Obes Res 2004, 12:454-460.
20. Strindberg L., Lonnroth P. Validation of an endogenous reference technique for the calibration of microdialysis catheters. Scand J Clin Lab Invest 2000, 60:205-211.
21. Sturchler-Pierrat C., Abramowski D., Duke M., Wiederhold K.H., Mistl C., Rothacher S., Ledermann B., Burki K., Frey P., Paganetti P.A., Waridel C., Calhoun M.E., Jucker M., Probst A., Staufenbiel M., Sommer B. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci U S A 1997, 94:13287-13292.
22. Trickler W.J., Miller D.W. Use of osmotic agents in microdialysis studies to improve the recovery of macromolecules. J Pharmacol Sci 2003, 92:1419-1427.
23. Winter C.D., Iannotti F., Pringle A.K., Trikkas C., Clough G.F., Church M.K. A microdialysis method for the recovery of IL-1beta, IL-6 and nerve growth factor from human brain in vivo. J Neurosci Methods 2002, 119:45-50.